Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112


Heterogeneity in mouse spasmolytic polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression.

Weis VG, Sousa JF, LaFleur BJ, Nam KT, Weis JA, Finke PE, Ameen NA, Fox JG, Goldenring JR.

Gut. 2013 Sep;62(9):1270-9. doi: 10.1136/gutjnl-2012-302401. Epub 2012 Jul 7.


Macrophages promote progression of spasmolytic polypeptide-expressing metaplasia after acute loss of parietal cells.

Petersen CP, Weis VG, Nam KT, Sousa JF, Fingleton B, Goldenring JR.

Gastroenterology. 2014 Jun;146(7):1727-38.e8. doi: 10.1053/j.gastro.2014.02.007. Epub 2014 Feb 15.


A molecular signature of gastric metaplasia arising in response to acute parietal cell loss.

Nozaki K, Ogawa M, Williams JA, Lafleur BJ, Ng V, Drapkin RI, Mills JC, Konieczny SF, Nomura S, Goldenring JR.

Gastroenterology. 2008 Feb;134(2):511-22. doi: 10.1053/j.gastro.2007.11.058. Epub 2007 Dec 4.


Spasmolytic polypeptide-expressing metaplasia (SPEM) in the gastric oxyntic mucosa does not arise from Lgr5-expressing cells.

Nam KT, O'Neal RL, Coffey RJ, Finke PE, Barker N, Goldenring JR.

Gut. 2012 Dec;61(12):1678-85. doi: 10.1136/gutjnl-2011-301193. Epub 2011 Dec 23.


Spasmolytic polypeptide expressing metaplasia to preneoplasia in H. felis-infected mice.

Nomura S, Baxter T, Yamaguchi H, Leys C, Vartapetian AB, Fox JG, Lee JR, Wang TC, Goldenring JR.

Gastroenterology. 2004 Aug;127(2):582-94.


Mature chief cells are cryptic progenitors for metaplasia in the stomach.

Nam KT, Lee HJ, Sousa JF, Weis VG, O'Neal RL, Finke PE, Romero-Gallo J, Shi G, Mills JC, Peek RM Jr, Konieczny SF, Goldenring JR.

Gastroenterology. 2010 Dec;139(6):2028-2037.e9. doi: 10.1053/j.gastro.2010.09.005. Epub 2010 Sep 18.


Characterization of progressive metaplasia in the gastric corpus mucosa of Mongolian gerbils infected with Helicobacter pylori.

Shimizu T, Choi E, Petersen CP, Noto JM, Romero-Gallo J, Piazuelo MB, Washington MK, Peek RM Jr, Goldenring JR.

J Pathol. 2016 Aug;239(4):399-410. doi: 10.1002/path.4735. Epub 2016 Jun 22.


Current understanding of SPEM and its standing in the preneoplastic process.

Weis VG, Goldenring JR.

Gastric Cancer. 2009;12(4):189-97. doi: 10.1007/s10120-009-0527-6. Epub 2010 Jan 5. Review.


Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia.

Nam KT, Lee HJ, Mok H, Romero-Gallo J, Crowe JE Jr, Peek RM Jr, Goldenring JR.

Gastroenterology. 2009 Apr;136(4):1288-96. doi: 10.1053/j.gastro.2008.12.037. Epub 2008 Dec 13.


Altered metaplastic response of waved-2 EGF receptor mutant mice to acute oxyntic atrophy.

Ogawa M, Nomura S, Varro A, Wang TC, Goldenring JR.

Am J Physiol Gastrointest Liver Physiol. 2006 Apr;290(4):G793-804. Epub 2005 Nov 23.


Maturity and age influence chief cell ability to transdifferentiate into metaplasia.

Weis VG, Petersen CP, Weis JA, Meyer AR, Choi E, Mills JC, Goldenring JR.

Am J Physiol Gastrointest Liver Physiol. 2017 Jan 1;312(1):G67-G76. doi: 10.1152/ajpgi.00326.2016. Epub 2016 Nov 23.


Establishment of novel in vitro mouse chief cell and SPEM cultures identifies MAL2 as a marker of metaplasia in the stomach.

Weis VG, Petersen CP, Mills JC, Tuma PL, Whitehead RH, Goldenring JR.

Am J Physiol Gastrointest Liver Physiol. 2014 Oct 15;307(8):G777-92. doi: 10.1152/ajpgi.00169.2014. Epub 2014 Sep 4.


Oxyntic atrophy, metaplasia, and gastric cancer.

Goldenring JR, Nam KT.

Prog Mol Biol Transl Sci. 2010;96:117-31. doi: 10.1016/B978-0-12-381280-3.00005-1. Review.


Potentiation of oxyntic atrophy-induced gastric metaplasia in amphiregulin-deficient mice.

Nam KT, Varro A, Coffey RJ, Goldenring JR.

Gastroenterology. 2007 May;132(5):1804-19. Epub 2007 Mar 24.


Serum Level of Trefoil Factor 2 can Predict the Extent of Gastric Spasmolytic Polypeptide-Expressing Metaplasia in the H. pylori-Infected Gastric Cancer Relatives.

Kuo HY, Chang WL, Yeh YC, Tsai YC, Wu CT, Cheng HC, Yang HB, Lu CC, Sheu BS.

Helicobacter. 2017 Feb;22(1). doi: 10.1111/hel.12320. Epub 2016 May 25.


The Development of Spasmolytic Polypeptide/TFF2-Expressing Metaplasia (SPEM) During Gastric Repair Is Absent in the Aged Stomach.

Engevik AC, Feng R, Choi E, White S, Bertaux-Skeirik N, Li J, Mahe MM, Aihara E, Yang L, DiPasquale B, Oh S, Engevik KA, Giraud AS, Montrose MH, Medvedovic M, Helmrath MA, Goldenring JR, Zavros Y.

Cell Mol Gastroenterol Hepatol. 2016 May 17;2(5):605-624. eCollection 2016 Sep.


Emergence of spasmolytic polypeptide-expressing metaplasia in Mongolian gerbils infected with Helicobacter pylori.

Yoshizawa N, Takenaka Y, Yamaguchi H, Tetsuya T, Tanaka H, Tatematsu M, Nomura S, Goldenring JR, Kaminishi M.

Lab Invest. 2007 Dec;87(12):1265-76.


Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer.

Lee HJ, Nam KT, Park HS, Kim MA, Lafleur BJ, Aburatani H, Yang HK, Kim WH, Goldenring JR.

Gastroenterology. 2010 Jul;139(1):213-25.e3. doi: 10.1053/j.gastro.2010.04.008. Epub 2010 Apr 13.


Spasmolytic polypeptide-expressing metaplasia (SPEM) associated with gastric cancer in Iceland.

Halldórsdóttir AM, Sigurdardóttrir M, Jónasson JG, Oddsdóttir M, Magnússon J, Lee JR, Goldenring JR.

Dig Dis Sci. 2003 Mar;48(3):431-41.


Differentiation of the gastric mucosa III. Animal models of oxyntic atrophy and metaplasia.

Goldenring JR, Nomura S.

Am J Physiol Gastrointest Liver Physiol. 2006 Dec;291(6):G999-1004. Review.

Supplemental Content

Support Center